InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-21.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Kunin Jeffrey, Chief Executive Officer. Insider active across 1 company, notably NovaBay Pharmaceuticals, Inc.. Cumulatively, 9 filings have been logged. Breakdown: 5 buys · 4 sells. Total volume traded: €251k. History available since 22 November 2021. The latest transaction was filed on 6 December 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
1 shares@ US$1.810.0% of flowCommon StockSEC:0001437749-22-028672:0
5,960 shares@ US$2.10492.8% of flowCommon StockSEC:0001437749-22-028438:0
5,960 shares@ US$2.10492.8% of flowCommon StockSEC:0001437749-22-028029:0
291,368 shares@ US$0.158210.7% of flowCommon StockSEC:0001437749-22-022648:0
101,650 shares@ US$0.46250.080% mcap11.5% of flowCommon StockSEC:0001437749-21-028029:0
Canonical exit: 3 Mar 2022 (T+90)
262,369 shares@ US$0.4760.21% mcap30.5% of flowCommon StockSEC:0001437749-21-027935:0
Canonical exit: 2 Mar 2022 (T+90)
14,848 shares@ US$0.490.012% mcap1.8% of flowCommon StockSEC:0001437749-21-027850:0
Canonical exit: 1 Mar 2022 (T+90)
30,000 shares@ US$0.460.024% mcap3.4% of flowCommon StockSEC:0001437749-21-027708:0
Canonical exit: 28 Feb 2022 (T+90)
25,000 shares@ US$0.460.020% mcap2.8% of flowCommon StockSEC:0001437749-21-027396:0
Canonical exit: 20 Feb 2022 (T+90)
9 of 9 declarations
About Kunin Jeffrey
Jeffrey Kunin is the President of DERMAdoctor, LLC and Chief Executive Officer of NovaBay Pharmaceuticals, Inc. He leads the company's operations with a focus on innovation and growth. His role is essential in ensuring the organization's success.
